Back to News
Market Impact: 0.12
Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™
Source: Business Wire
Healthcare & BiotechArtificial IntelligencePrivate Markets & Venture
Lōkahi Therapeutics partnered with Pepperdine E2B to expand its ai² Pipeline, engaging MBA students to evaluate biopharmaceutical assets. The collaboration is a modestly positive development for the company's asset-sourcing and evaluation capabilities, but no financial terms, pipeline metrics, or commercial milestones were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- Great Bond Shakeout Locks In a 5% World ‘Until Something Breaks’
- OpenAI rogue agents leaked 53 images from ChatGPT users and reportedly created nearly 1 million links packing encoded bits of info
- Boom or bust? The case for and against panicking about 5% yields
- Bond market alarms are ringing on Wall Street. Here's what's ahead
- Shares of Akamai surge after deal with Anthropic. What Wall Street is saying
- The Tiny Magnet Maker That Attracted $1.6 Billion From Lutnick